Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.955
-0.015 (-0.51%)
At close: Aug 1, 2025, 4:00 PM
2.950
-0.005 (-0.17%)
After-hours: Aug 1, 2025, 7:22 PM EDT
Smartsheet Market Cap
Compass Therapeutics has a market cap or net worth of $407.93 million as of August 1, 2025. Its market cap has increased by 187.85% in one year.
Market Cap
407.93M
Enterprise Value
301.68M
1-Year Change
187.85%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has decreased from $435.34M to $407.93M, a decrease of -6.30%. That is a compound annual growth rate of -1.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 407.93M | 104.47% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 664.39B |
| Johnson & Johnson | 396.75B |
| AbbVie | 333.89B |
| AstraZeneca | 232.21B |
| UnitedHealth Group | 226.39B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 219.63B |
| Novo Nordisk | 213.92B |